Skip to main content
Log in

Lower extremity stress fractures during intermittent cyclical etidronate treatment for osteoporosis

  • Comment
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

During intermittent cyclical etidronate treatment, a lower extremity pain syndrome associated with stress fractures was observed in three osteoporotic patients. This report describes the development of stress fractures during initial cycles of treatment, with recurrence of symptoms in two patients when etidronate therapy was resumed. Further studies are needed to confirm whether stress fractures are associated with cyclic etidronate treatment and if so, the incidence and pathophysiology need to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schnitzler CM, Solomon L (1985) Trabecular stress fractures during fluoride therapy for osteoporosis. Skeletal Radiol 14:276–279

    Google Scholar 

  2. Schulz EE, Libanati CR, Farley SM, Kirk GA, Baylink DJ (1984) Skeletal scintigraphic changes in osteoporosis treated with sodium fluoride. J Nucl Med 25:651–655

    Google Scholar 

  3. O'Duffy JD, Wahner HW O'Fallon WM et al (1986) Mechanism of acute lower extremity pain syndrome, in fluoride-treated osteoporotic patients. Am J Med 8:561–566

    Google Scholar 

  4. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265–1271

    Google Scholar 

  5. Watts NB, harris ST, Genant HK, et al (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73–79

    Google Scholar 

  6. Riggs BL, Hodgson SF, O'Fallon WM, Chao EYS, Wahner HW, Muhs JM et al (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802–809

    Google Scholar 

  7. Gibbs CJ, Aaron JE, Peacock M (1986) Osteomalacia in Paget's disease treated with short-term, high-dose sodium etidronate. Br Med J 292:1227–1229

    Google Scholar 

  8. Storm T, Steiniche T, Thamsborg G, Melsen F (1993) Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res 8:199–208

    Google Scholar 

  9. Rusell RGG (1984) Paget's disease. In: Nordin BEC (ed) Metabolic bone and stone disease, 2nd ed. Churchill Livingstone, Edinburch

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guañabens, N., Peris, P., Monegal, A. et al. Lower extremity stress fractures during intermittent cyclical etidronate treatment for osteoporosis. Calcif Tissue Int 54, 431–434 (1994). https://doi.org/10.1007/BF00305532

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00305532

Key words

Navigation